The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2053-2064

  Qin, Lili ^a   Wang, Mei ^a   Zhu, Rongrong ^a   You, Songhui ^a   Zhou, Ping ^a   Wang, Shilong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Antitumor effect; Drug delivery; Etoposide; Layered double hydroxides; Sustained release

Indexed keywords

ETOPOSIDE; LAYERED DOUBLE HYDROXIDE NANOHYBRID; NANOPARTICLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; PARTICLE SIZE; PH; STRUCTURE ACTIVITY RELATION; SUSTAINED DRUG RELEASE; THERMOGRAVIMETRY; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

ANTITUMOR EFFECT; DRUG DELIVERY; ETOPOSIDE; LAYERED DOUBLE HYDROXIDES; SUSTAINED RELEASE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; ETOPOSIDE; GASTRIC JUICE; HUMANS; HYDROXIDES; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; NANOSTRUCTURES; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84878404354     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S43203     Document Type: Article

References (52)

1. Drewinko B, Barlogie B. Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213. Cancer Treat Rep. 1976; 60(9):1295-1306.
2. Hainsworth JD, Greco FA. Etoposide: twenty years later. Ann Oncol. 1995;6(4):325-341.
3. Slevin ML. Low-dose oral etoposide: a new role for an old drug? J Clin Oncol. 1990;8(10):1607-1609.
4. Lowis S P, Newell DR. Etoposide for the treatment of paediatric tumours: what is the best way to give it? Eur J Cancer. 1996;32A(13): 2291-2297.
5. You B, Tranchand B, Girard P, et al. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study. Lung Cancer. 2008;62(2):261-272.
6. Van Maanen JM, Retèl J, de Vries J, Pinedo HM. Mechanism of action of antitumor drug etoposide: a review. J Natl Cancer Inst. 1988;80(19): 1526-1533.
7. Shah JC, Chen JR, Chow D. Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res. 1989;6(5): 408-412.
8. Hainsworth JD, Williams SD, Einhorn LH, Birch R, Greco FA. Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial. J Clin Oncol. 1985;3(5):666-671.
9. Seida Y, Nakano Y. Removal of phosphate by layered double hydroxides containing iron. Water Res. 2002;36(5):1306-1312.
10. Kwon SJ, Choy JH. A novel hybrid of Bi-based high-Tc superconductor and molecular complex. Inorg Chem. 2003;42(25):8134-8136.
11. Xu Z P, Lu GQ. Layered double hydroxide nanomaterials as potential cellular drug delivery agents. Pure Appl Chem. 2006;78(9):1771-1779.
12. Xu Z P, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for effcient cellular delivery. Chem Eng Sci. 2006;61(3):1027-1040.
13. Choy JH, Kim YI, Kim B W, Campet G, Portier J, Huong P V. Grafting mechanism of electrochromic PAA-WO3 composite film. J Solid State Chem. 1999;142(2):368-373.
14. Choy JH, Yoon JB, Park JH. In situ XAFS study at the Zr K-edge for SiO2/ZrO2 nano-sol. J Synchrotron Radiat. 2001;8(Pt 2):782-784.
15. Kwak S Y, Kriven WM, Wallig MA, Choy JH. Inorganic delivery vector for intravenous injection. Biomaterials. 2004;25(28):5995-6001.
16. Hofer C, Teichert C, Wächter M, Bobek T, Lyutovich K, Kasper E. Nanostructure formation on ion-eroded SiGe flm surfaces. Superlattices and Microstructures. 2004;36(1-3):281-291.
17. Li A, Qin LL, Wang SL, et al. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials. 2011;32(2):469-477.
18. Aisawa S, Takahashi S, Ogasawara W, Umetsu Y, Narita E. Direct intercalation of amino acids into layered double hydroxides by copre-cipitation. J Solid State Chem. 2001;162(1):52-62.
19. Zhang H, Qi R, Evans DG, Duan X. Synthesis and characterization of a novel nano-scale magnetic solid base catalyst involving a layered double hydroxide supported on a ferrite core. J Solid State Chem. 2004;177(3):772-780.
20. Hibino T, Nishiyama T. Role of TGF-beta2 in the human hair cycle. J Dermatol Sci. 2004;35(1):9-18.
21. Wong KK, Colfen H, Whilton NT, Douglas T, Mann S. Synthesis and characterization of hydrophobic ferritin proteins. J Inorg Biochem. 1999;76(3-4):187-195.
22. Nakayama H, Hayashi A, Eguchi T, Nakamura N, Tsuhako M. Adsorption of formaldehyde by polyamine-intercalated α-zirconium phosphate. Solid State Sciences. 2002;4(8):1067-1070.
23. Wang G, Feng L, Luck RL, Evans DG, Wang Z, Duan X. Sol-gel synthesis, characterization and catalytic property of silicas modified with oxo-molybdenum complexes. J Mol Catal A Chem. 2005;241(1-2):8-14.
24. Zhang H, Zou K, Sun H, Duan X. A magnetic organic-inorganic composite: synthesis and characterization of magnetic 5-aminosali-cylic acid intercalated layered double hydroxides. J Solid State Chem. 2005;178(11):3485-3493.
25. Zhang H, Zou K, Guo S, Duan X. Nanostructural drug-inorganic clay composites: structure, thermal property and in vitro release of captopril-intercalated Mg-Al-layered double hydroxides. J Solid State Chem. 2006;179(6):1792-1801.
26. Xiao R, Wang WR, Pan L, et al. A sustained folic acid release system based on ternary magnesium/zinc/aluminum layered double hydroxides. J Mater Sci. 2011;46(8):2635-2643.
27. Qin LL, Wang SL, Zhang R, Zhu RG, Sun XY, Yao S. Two different approaches to synthesizing Mg-Al-layered double hydroxides as folic acid carriers. J Phys Chem Solids. 2008;69(11):2779-2784.
28. Qin L, Xue M, Wang W, et al. The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyl-lotoxin. Int J Pharm. 2010;388(1-2):223-230.
29. Li B, He J, Evans DG, Duan X. Enteric-coated layered double hydroxides as a controlled release drug delivery system. Int J Pharm. 2004; 287(1-2):89-95.
30. Choi SJ, Choy JH. Layered double hydroxide nanoparticles as target-specifc delivery carriers: uptake mechanism and toxicity. Nanomedicine (Lond). 2011;6(5):803-814.
31. Ambrogi V, Famiani F, Perioli L, Marmottini, Di Cunzolo I, Rossi C. Effect of MCM-41 on the dissolution rate of the poorly soluble plant growth regulator, the indole-3-butyric acid. Microporous and Mesoporous Materials. 2006;96(1-3):177-183.
32. Gu Z, Thomas AC, Xu Z P, Campbell JH, Lu GQ. In vitro sustained release of LMWH from MgAl-layered double hydroxide nanohybrids. Chem Mater. 2008;20(11):3715-3722.
33. Tyner KM, Schiffman SR, Giannelis E.P. Nanobiohybrids as delivery vehicles for camptothecin. J Control Release. 2004;95(3):501-514.
34. Xue YH, Zhang R, Sun XY, Wang SL. The construction and characterization of layered double hydroxides as delivery vehicles for podophyllotoxins. J Mater Sci Mater Med. 2008;19(3): 1197-1202.
35. Xu Z P, Walker TL, Liu KL, Cooper HM, Lu GQ, Bartlett PF. Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA. Int J Nanomedicine. 2007;2(2):163-174.
36. Li ZH. Sorption kinetics of hexadecyltrimethylammonium on natural clinoptilolite. Langmuir. 1999;15(19):6438-6445.
37. Yang JH, Han YS, Park M, et al. New inorganic-based drug delivery system of indole-3-acetic acid-layered metal hydroxide nano-hybrids with controlled release rate. Chem Mater. 2007;19(10): 2679-2685.
38. Demirbas E, Kobya M, Senturk E, Ozkan T. Adsorption kinetics for the removal of Cr (VI) from aqueous solutions on the activated carbons prepared from agricultural wastes. Water South Africa. 2004;30:533-539.
39. Kodama T, Harada Y, Ueda M, Shimizu KI, Shuto K, Komarneni S. Selective exchange and fxation of strontium ions with ultrafne Na-4-mica. Langmuir. 2001;17(16):4881-4886.
40. Sparks DL. Kinetics of Soil Chemical Processes. San Diego, CA: Harcourt Brace Jovanovich Publishers; 1989.
41. Choy JH, Jung JS, Oh JM, et al. Layered double hydroxide as an eff-cient drug reservoir for folate derivatives. Biomaterials. 2004;25(15): 3059-3064.
42. -in Mg/Al-hydrotalcite. American Mineralogist. 2000;87:623-629.
43. Tronto J, Crepaldi EL, Pavan PC, De Paula CC, Valim JB. Organic anions of pharmaceutical interest intercalated in magnesium aluminum LDHs by two different methods. Molecular Crystals Liquid Crystals. 2001;356(1):227-237.
44. Qian WY, Sun DM, Zhu RR, Du XL, Liu H, Wang SL. pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release. Int J Nanomedicine. 2012;7: 5781-5792.
45. bin Hussein MZ, Zainal Z, Yahaya AH, Foo DW. Controlled release of a plant growth regulator, alpha-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J Control Release. 2002;82(2-3):417-427.
46. Pan DK, Zhang H, Zhang T, Duan X. A novel organic-inorganic microhybrids containing anticancer agent doxifuridine and layered double hydroxides: Structure and controlled release properties. Chem Eng Sci. 2010;65(12):3762-3771.
47. Choy JH, Kwak S Y, Park JS, Jeong YJ. Cellular uptake behavior of [γ-32P] labeled ATP-LDH nanohybrids. J Mater Chem. 2001;11(6): 1671-1674.
48. Oh JM, Choi SJ, Lee GE, Kim JE, Choy JH. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chem Asian J. 2009;4(1):67-73.
49. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
50. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189-207.
51. Fahmy TM, Fong PM, Goyal A, Saltzman WM. Targeted nanoparticles for drug delivery. Materials Today. 2005;8(8 Suppl 1):18-26.
52. Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm. 2008;348(1-2):137-145.